March 2025

SILVER SPRING, Md., March 4, 2025 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA approved the first generics of Xarelto (rivaroxaban), 2.5 mg, tablets to reduce the risk of major cardiovascula

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: